AstraZeneca and Amgen have received U.S. Food and Drug Administration (FDA) approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance treatment for adults and adolescents aged 12 and ...

As the weather begins to shift, many people find themselves struggling with seasonal health issues like cold, cough, and flu. The mornings and evenings are turning chilly, while the afternoons remain ...